James B. Renacci bought Abbott Laboratories (NYSE: ABT)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 6 trades in Abbott Laboratories (ABT) since 2012, 4 purchases and 2 sales, worth an estimated $189K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $15,001 - $50,000 of Abbott Laboratories (NYSE: ABT) on August 14, 2012. Since that trade, ABT is up +343.96% against the S&P 500 up +558.87%, an outperformance of -214.91%.
Across these filings, James B. Renacci has been a net buyer of ABT (a buy-to-sell ratio of 2.00). The most recent disclosed ABT transaction shown was dated October 24, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's ABT trades vs the price
ABT is up +343.96% since James B. Renacci bought on August 14, 2012, versus +558.87% for the S&P 500.
Performance since this trade
All James B. Renacci ABT trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & ABT trading FAQ
Is it legal for James B. Renacci to trade Abbott Laboratories (ABT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy ABT?
James B. Renacci disclosed a purchase of $15,001 - $50,000 of Abbott Laboratories (ABT) on August 14, 2012, according to public STOCK Act filings.
How has ABT performed since James B. Renacci's trade?
Since James B. Renacci bought ABT on August 14, 2012, the stock is up +343.96%, versus +558.87% for the S&P 500 over the same period, an outperformance of -214.91%.
How many times has James B. Renacci traded ABT?
James B. Renacci has disclosed 6 ABT trades since 2012 (4 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ABT trades?
Quantellect tracks every disclosed congressional trade in Abbott Laboratories (ABT) on the Abbott Laboratories congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's ABT tradesAll congressional filings for Abbott LaboratoriesJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.